JP2002514649A5 - - Google Patents

Download PDF

Info

Publication number
JP2002514649A5
JP2002514649A5 JP2000548338A JP2000548338A JP2002514649A5 JP 2002514649 A5 JP2002514649 A5 JP 2002514649A5 JP 2000548338 A JP2000548338 A JP 2000548338A JP 2000548338 A JP2000548338 A JP 2000548338A JP 2002514649 A5 JP2002514649 A5 JP 2002514649A5
Authority
JP
Japan
Prior art keywords
group
formula
alkyl
compound
atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000548338A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002514649A (ja
Filing date
Publication date
Priority claimed from DE19820599A external-priority patent/DE19820599A1/de
Application filed filed Critical
Publication of JP2002514649A publication Critical patent/JP2002514649A/ja
Publication of JP2002514649A5 publication Critical patent/JP2002514649A5/ja
Withdrawn legal-status Critical Current

Links

JP2000548338A 1998-05-08 1999-05-07 エポチロン誘導体、それらの製造方法、並びにそれらの使用 Withdrawn JP2002514649A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19820599A DE19820599A1 (de) 1998-05-08 1998-05-08 Epothilonderivate, Verfahren zu deren Herstellung und deren Verwendung
DE19820599.6 1998-05-08
PCT/EP1999/003159 WO1999058534A2 (de) 1998-05-08 1999-05-07 Epithilonderivate, verfahren zu deren herstellung und deren verwendung

Publications (2)

Publication Number Publication Date
JP2002514649A JP2002514649A (ja) 2002-05-21
JP2002514649A5 true JP2002514649A5 (https=) 2006-06-29

Family

ID=7867085

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000548338A Withdrawn JP2002514649A (ja) 1998-05-08 1999-05-07 エポチロン誘導体、それらの製造方法、並びにそれらの使用

Country Status (14)

Country Link
US (2) US6982280B1 (https=)
EP (1) EP1077980B1 (https=)
JP (1) JP2002514649A (https=)
KR (1) KR20010052325A (https=)
AR (1) AR018344A1 (https=)
AT (1) ATE234842T1 (https=)
AU (1) AU754212B2 (https=)
CA (1) CA2330812A1 (https=)
DE (2) DE19820599A1 (https=)
ES (1) ES2195577T3 (https=)
HU (1) HUP0102283A3 (https=)
IL (1) IL139480A0 (https=)
TW (1) TW568910B (https=)
WO (1) WO1999058534A2 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204388B1 (en) 1996-12-03 2001-03-20 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
CA2273083C (en) 1996-12-03 2012-09-18 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
GB9810659D0 (en) 1998-05-18 1998-07-15 Ciba Geigy Ag Organic compounds
US6518421B1 (en) 2000-03-20 2003-02-11 Bristol-Myers Squibb Company Process for the preparation of epothilone analogs
SI1483251T1 (sl) 2002-03-12 2010-03-31 Bristol Myers Squibb Co C cian epotilonski derivati
DE10355223A1 (de) 2003-11-26 2005-06-30 Institut für Pflanzenbiochemie (IPB) Neue Makrocyclen zur Behandlung von Krebserkrankungen
EP1674098A1 (en) 2004-12-23 2006-06-28 Schering Aktiengesellschaft Stable and tolerable parental formulations of highly reactive organic drug substances with low or no solubility in water
US7754850B2 (en) 2005-02-11 2010-07-13 University Of Southern California Chimeric disintegrin domain
JP2009532035A (ja) 2006-03-31 2009-09-10 ブリストル−マイヤーズ スクイブ カンパニー 微小管安定化剤に対する感受性を決定するためのバイオマーカーおよび方法
EP2029156A4 (en) * 2006-05-01 2010-07-21 Univ Southern California COMBINATION THERAPY FOR CANCER TREATMENT
EP2065054A1 (en) 2007-11-29 2009-06-03 Bayer Schering Pharma Aktiengesellschaft Combinations comprising a prostaglandin and uses thereof
DE102007059752A1 (de) 2007-12-10 2009-06-18 Bayer Schering Pharma Aktiengesellschaft Funktionalisierte, feste Polymernanopartikel enthaltend Epothilone
EP2070521A1 (en) 2007-12-10 2009-06-17 Bayer Schering Pharma Aktiengesellschaft Surface-modified nanoparticles
US8802394B2 (en) 2008-11-13 2014-08-12 Radu O. Minea Method of expressing proteins with disulfide bridges with enhanced yields and activity
EP2210584A1 (en) 2009-01-27 2010-07-28 Bayer Schering Pharma Aktiengesellschaft Stable polymeric composition comprising an epothilone and an amphiphilic block copolymer
US20110300150A1 (en) 2010-05-18 2011-12-08 Scott Eliasof Compositions and methods for treatment of autoimmune and other disease
EP2793947B1 (en) 2011-12-23 2021-02-03 Innate Pharma Enzymatic conjugation of polypeptides
US10132799B2 (en) 2012-07-13 2018-11-20 Innate Pharma Screening of conjugated antibodies
EP3564259A3 (en) 2012-11-09 2020-02-12 Innate Pharma Recognition tags for tgase-mediated conjugation
US10611824B2 (en) 2013-03-15 2020-04-07 Innate Pharma Solid phase TGase-mediated conjugation of antibodies
EP3010547B1 (en) 2013-06-20 2021-04-21 Innate Pharma Enzymatic conjugation of polypeptides
CN105517577A (zh) 2013-06-21 2016-04-20 先天制药公司 多肽的酶促偶联
WO2019092148A1 (en) 2017-11-10 2019-05-16 Innate Pharma Antibodies with functionalized glutamine residues

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4138042C2 (de) * 1991-11-19 1993-10-14 Biotechnolog Forschung Gmbh Epothilone, deren Herstellungsverfahren sowie diese Verbindungen enthaltende Mittel
US5351146A (en) * 1993-03-01 1994-09-27 At&T Bell Laboratories All-optical network architecture
US5781537A (en) * 1995-07-07 1998-07-14 International Business Machines Corporation Setting up, taking down and maintaining connections in a communications network
DE19542986A1 (de) * 1995-11-17 1997-05-22 Biotechnolog Forschung Gmbh Epothilon-Derivate und deren Verwendung
JP4183099B2 (ja) 1995-11-17 2008-11-19 ゲゼルシャフト・フュア・ビオテヒノロジッシェ・フォルシュング・ミット・ベシュレンクテル・ハフツング(ゲー・ベー・エフ) エポチロンcおよびd、製造法ならびに組成物
ES2312695T3 (es) 1996-11-18 2009-03-01 Gesellschaft Fur Biotechnologische Forschung Mbh (Gbf) Epotilones e y f.
US6380394B1 (en) 1996-12-13 2002-04-30 The Scripps Research Institute Epothilone analogs
US6304349B1 (en) * 1998-06-30 2001-10-16 Lucent Technologies Inc. WDM optical communications networks and methods for provisioning
US6445844B1 (en) * 1999-09-15 2002-09-03 Xros, Inc. Flexible, modular, compact fiber optic switch
US7092633B2 (en) * 2000-11-14 2006-08-15 University Of Texas System Board Of Regents System and method for configuring optical circuits
US6982951B2 (en) * 2000-12-21 2006-01-03 At&T Corp. Method for selecting a restoration path in a mesh network
US7212495B2 (en) * 2001-02-21 2007-05-01 Polytechnic University Signaling for reserving a communications path
WO2002080428A2 (en) * 2001-03-29 2002-10-10 Atoga Systems, Inc. Open ring architectures for optical wdm networks
US20020194339A1 (en) * 2001-05-16 2002-12-19 Lin Philip J. Method and apparatus for allocating working and protection bandwidth in a telecommunications mesh network
WO2003003156A2 (en) * 2001-06-27 2003-01-09 Brilliant Optical Networks Distributed information management schemes for dynamic allocation and de-allocation of bandwidth

Similar Documents

Publication Publication Date Title
JP2002514649A5 (https=)
AU754212B2 (en) Epothilone derivatives, a method for the production thereof, and their use
NO992549L (no) Sukkerforbindelse, geleringsmiddel og fremgangsmåte for fremstilling derav
JP2004502756A5 (https=)
DK1063228T3 (da) Cycloalkenderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf
JP2005530811A5 (https=)
NO20045497L (no) Fremgangsmate for fremstilling av 5-(1,3-oksazol-2-yl)benzosyrederivater
JP2004530689A5 (https=)
SU701537A3 (ru) Способ получени нитрилов тиазол2-коричной кислоты
JP2004526767A5 (https=)
KR930007936A (ko) 이미다졸릴- 프로펜산 유도체
JPH11158169A (ja) 新規なクマリンのヒドロキシ及びポリヒドロキシ誘導体及びその製造方法
RU2004126861A (ru) Производные пиридинамидов в качестве ингибиторов моноаминоксидазы (мао-в)
RU94031745A (ru) Производные пиридобензоксадиазина, смесь их изомеров или отдельные изомеры, их гидраты и соли, способ их получения и фармацевтическая композиция с антибактериальной активностью
JP2952493B2 (ja) シクロペンタン誘導体
GB1363758A (en) Process for the production of 1,2,4-oxa-diazoles and novel 1,2,4- oxadiazoles
JP2005520805A5 (https=)
PE20030758A1 (es) 1,3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilizacion
TH1404B (th) อนุพันธ์ของอินโดลิซีนใหม่ และกรรมวิธีในการเตรียมอนุพันธ์นี้
ES8600188A1 (es) Procedimiento de preparacion de un derivado 1,1-difenilpropan-1-ol
JPS61186372A (ja) ベンゾチアゾ−ルの製造方法
JPH0225472A (ja) チアゾール誘導体及びその製造方法
JPH01313486A (ja) β―アルコキシカルボニルエチル錫ジチオカ―バメート誘導体、その製造方法およびそれを含有する殺菌剤
JPS58162568A (ja) 核置換ベンジル尿素誘導体およびその製造方法
TH808A (th) อนุพันธ์ของอินโดลิซีนใหม่ และกรรมวิธีในการเตรียมอนุพันธ์นี้